Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

SF Intra-city “SoFast” Debuts in Macau in Strategic Partnership with Macau’s “Aomi APP” Offering Full-Scenario One-hour Delivery Service

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Recently, Hangzhou SF Intra-city Industrial Co., Ltd. ("SF Intra-city", or the "Group"; Stock Code: 9699.HK), China's largest third-party on-demand...

Zeekr Group Announces Shareholders’ Approval of Merger Agreement

HANGZHOU, China, Sept. 15, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...